11:24 AM EDT, 08/07/2025 (MT Newswires) -- PharmAla Biotech ( MDXXF ) on Thursday said it completed customs clearance and delivery of over 500 capsules of its LaNeo 40mg MDMA to the Merhavim Mental Health Centre of Beer Yaakov, Israel.

All data generated in the clinical trial, entitled "MDMA Assisted Psychotherapy for PTSD of Early Sexual Trauma Compared to All Trauma in Adulthood", will be licensed to the company for regulatory and commercial purposes in exchange for the clinical trial material.

Shares of the company were last seen down $0.005 to $0.15 on the Canadian Securities Exchange.

Price: 0.15, Change: -0.01, Percent Change: -3.23